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Chronic use of alcohol is considered to be a potential risk factor for the incidence of type 2 diabetes mellitus (T2DM), which causes 
insulin resistance and pancreatic β-cell dysfunction that is a prerequisite for the development of diabetes. However, alcohol con-
sumption in diabetes has been controversial and more detailed information on the diabetogenic impact of alcohol seems warrant-
ed. Diabetes, especially T2DM, causes dysregulation of various metabolic processes, which includes a defect in the insulin-medi-
ated glucose function of adipocytes, and an impaired insulin action in the liver. In addition, neurobiological profiles of alcoholism 
are linked to the effects of a disruption of glucose homeostasis and of insulin resistance, which are affected by altered appetite that 
regulates the peptides and neurotrophic factors. Since conditions, which precede the onset of diabetes that are associated with al-
coholism is one of the crucial public problems, researches in efforts to prevent and treat diabetes with alcohol dependence, receives 
special clinical interest. Therefore, the purpose of this mini-review is to provide the recent progress and current theories in the 
interplay between alcoholism and diabetes. Further, the purpose of this study also includes summarizing the pathophysiological 
mechanisms in the neurobiology of alcoholism.
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Diabetes mellitus (DM) is recognized clinically as a complica-
tion of alcoholism, and both alcoholism and DM affect a large 
population worldwide [1]. Chronic, heavy alcohol consump-
tion, an independent risk factor for type 2 diabetes mellitus 
(T2DM) [2], disrupts the glucose homeostasis and is associat-
ed with development of insulin resistance [3]. However, epide-
miological and controlled clinical data on the relationship be-
tween the amount of ingested alcohol and the incidence of 
T2DM have been inconsistent in literature. There is a delicate 
balance between the harmful effects and the beneficial effects 
of alcohol on T2DM. While some studies have reported that 
moderate and sensible alcohol use decreases the risk of T2DM 
[4] or heavy alcohol use increases the risk of T2DM, with the 
loss of glycemic control [5], others have suggested that there 
exists no effects [6]. Whether these effects might be due to gen-
der differences or not, it has been shown with to be inconsis-
tent and the impact of alcohol on pre-diabetes impaired fast-
ing glucose (IFG) or impaired glucose tolerance (IGT) has 
rarely been investigated [7]. Notably, heavy amounts of alco-
hol show direct diabetogenic effects with its contribution to 
excess caloric intake and obesity, induction of pancreatitis, 
disturbance of the carbohydrate and glucose metabolism and 
the impairment of the liver function, which affects the blood 
glucose levels, which causes hypoglycemia [8]. In T2DM pa-
tients, increased insulin resistance in key metabolic tissues, 
such as skeletal muscle, liver and adipose tissue, is coupled with 
the reduced insulin secretion caused by impaired β-cell func-
tion in the pancreas [9]. The impaired response to insulin and 
β-cell failure in the setting of alcohol-related insulin resistance, 
therefore, is critical in defining the risk and development of 
T2DM. 
  In this article, we review recent studies on the association 
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between alcohol consumption and the incidence of diabetes 
and suggested underlying mechanisms that is focused on in-
sulin resistance. Furthermore, this review describes the appe-
tite regulating peptides, particularly ghrelin and leptin, along 
with the brain-derived neurotrophic factor (BDNF) that have 
been proposed as the basis for promising new therapies for di-
abetes.
ALCOHOL CONSUMPTION AND GLUCOSE 
METABOLISM
There is now quite some evidence that chronic heavy consump-
tion of alcohol has deleterious effect on metabolic control and 
may even be associated with impaired insulin resistance. The 
pancreatic islet β-cells normally increase the insulin release 
sufficiently to overcome the reduced efficiency of insulin ac-
tion. Thereby, maintaining normal glucose tolerance. Howev-
er, chronic heavy alcohol use leads to impaired glucose toler-
ance, which is a combination of impaired secretion of insulin 
and a reduced insulin sensitivity or resistance. Glucose intol-
erance is the transition phase between normal glucose toler-
ance and diabetes, also referred to as prediabetes. 
  Plausible mechanisms mediating the association, between 
alcohol intake and glucose intolerance, have been hypothe-
sized that disruption glucose homeostasis that may provide a 
specific mechanism by which, a chronic heavy ethanol con-
sumption increases the incidence of T2DM. Meanwhile, com-
pared to researches on the relationship between alcohol con-
sumption and diabetic risk, among non-diabetic population, 
effects of alcohol on glycemic control in patients with T2DM 
have been studied at a much lower frequency. In alcoholism 
patients, diabetes has relevance to reduced insulin resistance, 
which is associated with chronic pancreatitis [10] or insulin 
secretion that is associated with alcohol-induced liver changes 
[11]. In general, when a shortage of glucose is impending, glu-
cose will be secreted from glycogen stores in the liver, but gly-
cogenolysis is also impaired by alcohol in which normal blood 
glucose levels cannot be maintained by the depletion of stores 
and hypoglycemia, which consequently may occur. Besides, 
continued alcohol metabolism causes diminished gluconeo-
genesis. Both the depletion of glycogen and diminished gluco-
neogenesis lead to lower blood glucose levels, as well as insulin 
secretion that is also reduced as the level of blood glucose falls. 
  Several findings concerning the involvement of chronic, 
heavy alcohol consumption in glucose metabolism is negative-
ly correlated with that of insulin concentrations, in addition to 
the fasting insulin levels. It has been reported that chronic high 
doses of alcohol alone have been exhibited to be efficient in 
producing reversible insulin resistance [12]. High concentra-
tions of ethanol may lead to reduced insulin binding [13] and 
inhibition of intracellular signalling related to that of insulin 
[14]. Moreover, alcohol dependence was one of the concomi-
tant factors in subjects with impaired glucose tolerance that 
are diagnosed with performing standard 75 g oral glucose tol-
erance test. This suggests that alcohol might impair fasting and 
postprandial glycemic controls and thus, alcohol consumption 
may be a risk factor for T2DM [15]. Extensive studies using 
animal models of chronic alcohol intake have provided insight 
into the possible mechanisms, which contributes to the devel-
opment of diabetes. Previously, our study demonstrated that 
chronic heavy drinking aggravates T2DM. In this study, diabet-
ic rats with chronic alcohol consumption showed lower fasting 
plasma glucose level, but significantly higher postprandial 
plasma glucose level that was difficult to return to baseline lev-
els than the non-drinking diabetic rats. On the other hand, this 
effect of ethanol on glucose levels was not observed in the non-
diabetic rats, which indicate that the diabetic state appears to 
be more susceptible to heavy alcohol ingestion than those in 
the non-diabetic state [16]. However, more attention needs to 
be paid to impact of chronic alcohol consumption on the glu-
cose metabolism and insulin resistance that have already been 
described in patients with T2DM.
  As noted above, the studies on glucose tolerance and insulin 
resistance in alcoholism focused on the impact of chronic heavy 
use of alcohol on the development of T2DM. Accordingly, de-
terioration in glucose homeostasis and insulin secretion in al-
cohol dependence may not only represent a consequence of 
T2DM, but also plays an important role in its cause, as well as 
its treatment.
PATHOPHYSIOLOGY OF DM
DM is a syndrome of disordered metabolism with abnormally 
high blood glucose levels, as a result of abnormal insulin se-
cretion and/or signaling (hyperglycemia) [17]. Hypoglycemia 
shows abnormally low levels of glucose in the blood, which in-
terfere with the function of organ system. The two most com-
mon forms of DM are type 1 (T1DM) and type 2 diabetes, with 
T1DM accounting for approximately 10% of all cases in Cau-
casians [18]. 110
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  T1DM (insulin-dependent diabetes) results due to autoim-
mune progressive destruction of insulin-secreting β-cells of 
the pancreas by CD4
+ and CD8
+ T cells and macrophage infil-
trating the islets [19]. The hormone insulin, secreted by the 
pancreas, involved in regulating body’s blood glucose levels 
and other metabolic function. Most importantly, blood glucose 
is taken up into the muscle and fat tissues, by insulin, and ex-
isting glucose is converted into a storage form (i.e., glycogen), 
thereby lowering the blood glucose levels (e.g., after a meal). 
As a result of the immune system attack, the pancreas does not 
produce sufficient insulin. It usually occurs in childhood or 
adolescence, but can develop at any age. 
  In contrast, T2DM (non-insulin dependent diabetes) con-
tinue to produce insulin in the early phase of the disease; how-
ever, the body resists insulin’s effect. Initially, resistance can be 
overcome by increasing insulin production. Eventually, the 
body can no longer produce enough insulin. A deficit in insu-
lin secretion, coupled with the state of insulin resistance, leads 
to T2DM [20]. In most patients, the disease develops over age 
40. Therefore, T1DM is characterized by a complete lack of in-
sulin production, whereas, T2DM is characterized by a reduc-
tion of insulin production plus resistance [21]. Unlike T1DM, 
where insulin therapy can provide effective relief, T2DM re-
quires treatment of insulin resistance, in addition to insulin 
secretion defects. 
  Hypoglycemia is defined as a state in which there are neu-
roglycopenic symptoms concurrent with a low blood glucose 
level. The definition of “low blood glucose” can differ signifi-
cantly across the major medical associations. Although in gen-
eral, T2DM shows a less hypoglycemia risk, when compared 
to that of T1DM, the frequency of hypoglycemia increases with 
increased diabetes and insulin treatment duration in T2DM 
[22]. In patients with either T1DM or T2DM, the root cause of 
factual hypoglycemia is always hyperinsulinemia. However, the 
etiology of hyperinsulinemia varies depending on the type of 
treatment strategy. For T1DM, hypoglycemia is always due to 
excessive insulin dosage. In T2DM, it results from the use of 
insulin or sulfonureas. The combination of a GLP-1 agent and 
a sulfonurea is a potent mixture and may cause lower than nor-
mal blood glucose levels (i.e., hypoglycemia). 
ALCOHOL CONSUMPTION AND RISK OF 
T2DM
There are several studies conducted to determine if chronic use 
of alcohol could be susceptible to a defective glucose tolerance, 
decreased insulin sensitivity, as well as an increased insulin re-
sistance that implied elevated risk of developing T2DM. T2DM 
is characterized by a defect in insulin-mediated glucose uptake 
in the muscle, an impaired insulin secretion by pancreatic 
β-cells, a disruption of secretary function of adipocytes, and 
dysfunction of insulin action in the liver, which affects the 
whole body glucose homeostasis [23]. Impaired insulin signal-
ling, combined with the eventual exhaustion of β-cell insulin 
production, causes T2DM. The development of both insulin 
resistance and impaired glucose tolerance, conditions that pre-
cede the onset of T2DM, are closely linked with alcoholism. 
  In T2DM, insulin sensitivity is reduced, while insulin secre-
tion may be increased, resulting in hyperinsulinemia, espe-
cially in the early phase of the disease, or decreased, in com-
parison to the healthy subjects, with normal glucose tolerance 
[24]. The priming effect of alcohol-enhanced insulin secretion 
in pancreatic β-cells might be caused by an early defence mech-
anism, which is used to compensate for alcohol-inhibited bas-
al insulin secretion. In contrast, a limited number of studies 
have reported deleterious effects of alcohol on β-cells, in which 
alcohol inhibited the insulin secretion [25]. As a result of β-cell 
dysfunction and inadequate insulin release, postprandial and 
subsequently fasting glucose levels increased, due to incomplete 
suppression of hepatic glucose production and decreased effi-
ciency of liver and muscle glucose uptake. The extremely ele-
vated blood glucose levels, with frequently observed diabetes, 
might contribute to further disease progression through the 
glucotoxic effects on the β-cell and harmful effects on insulin 
sensitivity, both of which can be ameliorated by therapeutical-
ly lowering the glucose level [26]. 
  In addition, T2DM patients are typified by a decreased fat 
oxidative capacity and elevated levels of circulating free fatty 
acid [27]. The letter is known to cause insulin resistance by re-
ducing stimulated glucose uptake, which most likely accumu-
lated in the lipid inside the muscle cell [28]. A reduced fat oxi-
dative capacity and metabolic inflexibility are important com-
ponents of muscle insulin resistance [29]. Heavy alcohol con-
sumption increases ROS production and may be a mechanism 
of pancreatic β-cells dysfunction in T2DM. The reason is that 
ROS production is one of the earliest events in glucose intoler-
ance, through mitochondrial dysfunction. Further, β-cells are 
very sensitive to oxidative stress [30]. Previous studies of alco-
hol dependence have shown that alcohol elevated the level of 
β-cell apoptosis and increased insulin resistance in the liver and 111
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skeletal muscle, which is among the earliest detectable altera-
tions in humans with T2DM [20]. These studies demonstrated 
the diabetes-related lipid abnormalities, by insulin sensitivity, 
mediated oxidative stress and the altered metabolism has been 
shown to have a deleterious effects after heavy drinking, an ef-
fect mediated by insulin.
A POSSIBLE PATHOPHYSIOLOGICAL 
MECHANISM 
Appetite regulating peptides, particularly ghrelin and 
leptin
One mechanism through which chronic use of alcohol might 
affect numerous processes that are aligned with neuroendocri-
nology of T2DM is through the alteration of appetite regulat-
ing peptides, particularly, ghrelin and leptin. It has been con-
sistently found that neurobiological profiles of alcohol depen-
dence are linked to the effects of T2DM, which are affected by 
the altered levels of ghrelin and leptin, which regulate food 
seeking behavior that have similar mechanism of controlling 
of alcohol craving behavior [31].
  Ghrelin is the most potent endogenous orexigenic peptide 
of gastric origin that plays a proliferative or protective role on 
β-cells [32] and stimulates insulin secretion, which primarily 
occurs in the response to that of the increased circulation of 
glucose levels, whereas insulin reduced the plasma ghrelin lev-
el in normal control and T2DM patients [33]. Moreover, ghre-
lin may decline endogenous glucose production, through su-
pression of insulin secretory capacity [34], while reinforcing 
insulin action on the glucose disposal [35]. Leptin is an adipo-
cyte-derived anorexic peptide that play a crucial role in regu-
lating the metabolism of glucose overall and particularly glu-
cose metabolism that suppresses the production of ghrelin via 
increase in insulin secretion and glucose utilization, along with 
the leptin exerts that elevates the ability in the development of 
diabetogenic imbalance, such as development of pancreatic 
β-cell dysfunction, insulin resistance, obesity, impairment of 
liver function in glucose metabolism by utilizing different 
mechanisms concurrently and sequentially [36]. In addition, 
therapeutic administration of insulin during 1 year resulted in 
increased the mean body weight and leptin concentrations, 
suggesting that insulin stimulated leptin secretion, which was 
believed to mediate the increase body weight [37]. Further, long 
period of leptin treatment led to decreased insulin-stimulated 
glucose utilization in skeletal muscle [38]. 
  Alcoholic patients with T2DM have repeatedly been found 
to have deregulation of the ghrelin and leptin systems, as indi-
cated by impaired insulin secretion, increased hepatic glucose 
production and decreased peripheral glucose utilization. We 
recently reported that leptin potentially plays a role in the 
pathogenesis of T2DM affected by the insulin resistance in pa-
tients with alcohol dependence. Our results confirm the exis-
tence of significant correlation between leptin and the fasting 
insulin concentration, β-cell function and insulin resistance 
and also, alcohol consumption, might produce leptin resistance 
despite the study that will be needed to determine the mecha-
nism of the relationship between alcohol intake and leptin re-
sistance. Collectively, ghrelin and leptin appears to exert a wide 
functional interaction between these peptides, which may con-
tribute significantly to the overall diabetogenic effects of chron-
ic alcohol consumption, and are being further investigated. 
BDNF
Given the data indicating decreased BDNF in alcoholism, there 
has been considerable interest in the possibility that chronic 
alcohol ingestion may impart its negative effects on T2DM, 
through its effects on BDNF. BDNF, a member of the neuro-
trophin family, mediated through a specific Trk family recep-
tor tyrosine kinase B (Trk A, Trk B, and Trk C), is abundantly 
expressed in central and peripheral nervous system [39]. BDNF 
have received attention, regarding a possible role in regulating 
neuronal survival, differentiation, synaptic plasticity, cognitive 
function and memory. 
  The latter findings were low circulating levels of BDNF in 
individual with T2DM and the severity of insulin resistance by 
the homeostasis model assessment index, which is based on 
fasting glucose and insulin levels [40]. BDNF might also regu-
late glucose metabolism and reduces food intake and lowers 
blood glucose in the obese diabetic mice [41]. Further, some 
of the cognitive deficits observed in T2DM may be directly at-
tributed to the impact of either high glucose levels or insulin 
glucose tolerance [42,43]. The decrement in memory function 
observed in subjects with impaired glucose regulation appears 
to be associated with hippocampal function and could be at-
tributed to decreases in extracellular glucose levels in the hip-
pocampus. Likewise, insulin, which plays a role in glucose 
transport in certain brain cell populations, through insulin-
sensitive glucose transporters (GLUT4 and GLUT8) in various 
brain regions, including the hippocampus [44]. Interestingly, 
the effects of BDNF on T2DM and its association with cogni-112
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tive functions, such as learning and memory, have been inves-
tigated [45]. Both experimental and clinical research have 
shown that BDNF plays a critical role in insulin resistance, a 
pathogenic feature of T2DM, indicating that BDNF is a regu-
lator of glucose metabolism by directly acting on the hypo-
thalamus [41], and is thought to have a protective effect on the 
pancreatic islets [46]. However, the exact mechanism of BDNF 
linked to the pathophysiology of T2DM after alcohol ingestion 
has also not been completely understood as of yet.
  Several investigators have addressed the impact of alcohol 
on the development of T2DM, affected by altered levels of 
BDNF, which modulate the activity of neurotransmitters, en-
hance cellular growth, and participate in neuronal plasticity 
[47]. Decreased in BDNF levels after chronic ethanol exposure 
supports the concept that ethanol-induced cell damage, which 
might be affected by BDNF, suggesting that BDNF involved in 
the process of neurogenesis is one of major targets of ethanol 
toxicity [48], as well. Recent research regarding alterations of 
BDNF in maintenance of alcohol dependence have showed 
that the acute administration of ethanol elevated the expres-
sion of BDNF mRNA in hippocampus neurons and that BDNF 
regulated the behavioral response to ethanol, but was decreased 
after continuous exposure [49]. There are possible underlying 
mechanisms of the homeostatic pathway, appearing that the 
potentiated release of dopamine and serotonin in striatal neu-
rons by BDNF stimulation [50], the induction of receptors for 
activated protein kinase C (RACK1) expression and the dopa-
mine D3 receptor [51], the alleged downstream component of 
the BDNF/RACK1 cascade, and successive changes in synap-
tic plasticity [52]. 
  Much of our recent focus has been the role of BDNF, as an 
important regulator in the glucose metabolism and BDNF may 
be associated with an increased risk of T2DM in alcoholism. 
Our study reported that chronic heavy drinking-induced de-
creases the serum BDNF levels in a rat model of T2DM [16]. 
In this study, alcohol-treated rats presented significantly lower 
plasma BDNF level, than compared to those in the non-diabet-
ic and non-alcohol-treated rats, which suggests that chronic 
heavy alcohol use and T2DM may create a synergic effect in 
the reduction of BDNF level. Alcohol-treated diabetic rats also 
presented significantly lower fasting plasma glucose level, but 
significantly higher postprandial plasma glucose, than those 
in the non-alcohol-treated diabetic rats. Findings of this study 
proposed that decreased BDNF may mediate between chronic 
alcohol consumption and aggravation of postprandial glyce-
mic control. Moreover, the decreased level of BDNF in the al-
cohol dependent patients in our study might be a reflection of 
the damaged BDNF/RACK1-related homeostatic pathway [53]. 
  Consequently, BDNF have an important physiological func-
tion in alcohol metabolism, as well as roles in glucose metabo-
lism and insulin resistance. Alcohol dependent subjects were 
found to have decreased plasma BDNF levels and impaired in-
sulin resistance, which is a major pathogenic feature of T2DM. 
This might indicate that BDNF may be linked to the pathophys-
iology of T2DM after alcohol use. 
Hippocampal long-term potentiation (LTP)
Hippocampal LTP, a functional marker of synaptic plasticity, 
is considered to be the basis in studying nervous and molecu-
lar mechanism of learning and memory [54]. Although there 
is accumulated evidence between T2DM and chronic heavy 
alcohol consumption, which is associated with the impairment 
of hippocampus-dependent cognitive functions, the combined 
effect on hippocampal LTP remains to be determined. In ani-
mal experimental studies that showed both, special learning 
and LTP expression in the hippocampus, were impaired in se-
verely hyperglycemic rats as compared with those in the non-
diabetic controls, however, spatial learning and hippocampal 
LTP were unaffected in moderately hypoglycemic rats, in mor-
ris water maze tests [55].
  Interesting conceptual notions connecting the impact of 
chronic heavy use of alcohol and T2DM on hippocamal LTP 
processes also have been elaborated from alteration of endog-
enous BDNF. BDNF, acting through its TrkB receptor, plays a 
role in the synaptic plasticity and positively moderates process-
es, which leads to a stable LTP in hippocampus [56], as well as 
glucose metabolism in diabetes [41]. Recently, there has been 
a report that showed chronic heavy drinking decreases the se-
rum BDNF levels in OLETF rats that provide a model for the 
pathophsiology of human T2DM [16], and decreased BDNF 
was also observed in rats displaying insulin resistance and LTP 
[57]. These studies suggest that better glycemic control im-
proves cognition and that there is a cognitive benefit to im-
proving BDNF level in T2DM. The fact that alcohol induced 
brain damages and cognitive dysfunction might precede other 
complications of alcohol, strongly suggests the need for research 
on their relationship. Alcohol-induced brain damages were 
commonly observed in otherwise, uncomplicated alcoholics 
[58]. Thus, brain is one of the most vulnerable organs from al-
cohol-induced toxicity. 113
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  In line with these, we recently reported that chronic heavy 
drinking impairs hippocampal long-term potentiation (LTP) 
in rat model of T2DM [59]. Considering that significantly low-
er fasting and postprandial glucose levels and relatively less 
weight gain of diabetic rats, with chronic heavy alcohol con-
sumption compared to those of diabetic rats that never drink, 
such impairment of LTP, is a notable finding. Hippocampus 
has a key cerebral structure, which is related to learning and 
memory, in particular, long-term memory and is especially 
sensitive to the deleterious effects of glucocorticoid that was 
deregulated in patients with T2DM [60], as well as in the indi-
viduals with acute and chronic alcohol consumption [58]. Our 
finding implied that chronic alcohol consumption further im-
pair hippocampal LTP, despite the non-aggravated glycemic 
control. Future clinical studies, using cognitive function test 
and neuroimaging modalities, will be needed. Thus, chronic 
heavy use of alcohol would be considered as a risk factor of 
potentiating cognitive decline in T2DM, which may increase 
the occurrence of pathopysiological changes associated with 
T2DM. 
SUMMARY AND CONCLUSION
The findings discussed here presents that the role of chronic 
use of alcohol on diabetes might be high of importance for 
clinical research and practice. The finding that was shown may 
also help to explain previous contradictory findings, regarding 
the association between alcoholism and diabetes. Chronic 
heavy consumption deteriorates glucose tolerance and insulin 
resistance, and this may well be one of the mechanisms involved 
in the malignant effect of alcohol, with regard to development 
of diabetes. In addition, appetite-regulating peptides, particu-
larly ghrelin and leptin, BDNF, and hippocampal LTP, which 
play important roles in the brain and insulin sensitivity, could 
become possible candidates for mediation that links T2DM 
and alcohol consumption. The novel mechanisms of these two 
appetite regulating peptides, BDNF and hippocampal LTP are 
widely involved in the neurobiology of alcohol dependence 
and T2DM. It deserves to be investigated more intensively in 
diabetogenic effects of chronic alcohol consumption. Therefore, 
understanding of the pathophysiological bases of these mech-
anisms should enhance better approaches to a potent thera-
peutic strategy for the treatment of both alcoholism and dia-
betes.
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